Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Mesoporous Silica in Biomedical Applications Luigi PASQUA Department of Environmental and Chemical Engineering University of Calabria Rende, ITALY During the last 20 years an evolution towards materials with larger pores than zeolites has been obtained. Ordered silica-based mesoporous materials named M41s were introduced at the beginning of the 1990s. Most of the synthesis approaches to form inorganic mesoporous materials are generally based on the use of organic template molecules. They organize themselves in sopramolecular formation around which the silica condensation occurs. The knowledge of several synthesis methods and of the parameters that affect the properties of the final material that constitutes the “field of existence of the mesoporous materials ” give the material chemist the possibility to engineerize in detail the system that he needs. Synthesis of mesoporous materials Choice a surfactant type and the specific synthesis mechanism A mesoporous materials is produced starting from the interaction of the silica source with the template molecules The first ordered mesoporous materials (IUPAC: 2 nm <dp < 50 nm) that were reported are known as the M41S-type of silica mesophases. They were first reported in 1992 by Mobil. The Mobil researchers introduced selfassembling surfactants as structure directing agents to direct the formation of the SiO2 mesostructured materials. The key parameters for the M41S synthesis are •the •the •the •the •the hydrogel composition, type and length of the surfactant, alkalinity, temperature and synthesis time. All M41S materials have well-defined uniform pores that are ordered in the long range. Among the applications: catalysis , sorption, separations, sensing, optics , drug delivery, drug targeting and several other biomedical applications can be cited. Synthesis Mechanism of Mesoporous Materials (S+ I-) Silica oligomers surfactant micelles Cylindric Aggregates Mesophase MCM-41 Calcination Micelles as templates for the addressing of silica condensation. MSU materials are prepared with nonionic polyethylene glycol polymers in neutral environment. Properties of Mesoporous Materials Silica framework High loading capacity (pore volume 0.5 – 1 cm3/g) Homogeneous and tunable pore size Versatile funtionalization Tunable surface properties (hydrophobic/hydrophilic) Basic/acid groups Hybridization of mesoporous silica Hybrid inorganic-organic materials are produced when chemically active groups are linked to the inorganic framework of mesoporous materials BY 1) Post Synthetic Grafting Or 2) Simultaneous condensation of siloxane and organo-siloxane precursors Chem. Commun., (1996) p.1367; Chem. Mater., 11 (1999) p. 3285; Microp. and Mesop. Mater.,27 (1999) p. 329. Post synthetic grafting Co-Condensation Pore system are suitably modified by chemicals Modifying agents have to be reactive toward silica walls Modifying agents can carry, other than the binding group, every kind of organic group on the opposite side of the molecule Appropriate active sites in terms of size polarity, presence of chelating agents or metals can be created. Surface properties of calcined and surfactant-extracted mesoporous materials Thermal treatment during calcination induces dehydroxylation making the surface strongly hydrophobic 3 Adsorbed volume (cm /g STP) 560 480 Des Aextr Ads Aextr Des Aextr Bz Ads Aextr Bz 400 320 240 160 80 0.0 0.2 0.4 0.6 Relative pressure P/P0 0.8 1.0 Sample Bz/(SiO2 + OH Bz + ads. conc. H2O) mol/100 (mass g ratio) Dry SiO2 Bz/(SiO2 + Bz) (mass ratio)** Bz/SiO2 + % of Bz OH (mol/100g) reacte d with Bz Acalc Bz 4.30·10-4 * 0.23 4.12·10-2 0.042 18 AextrBz 6.95·10-2 * 0.56 2.30·10-1 0.23 41 Table. Quantitative data on benzoyl and hydroxyl modification *Data obtained from UV quantitative measurements of hydrolysis solution **Data obtained from TG analyses Drug targeting devices with mesoporous materials Design of a multifunctional device able to target a drug: The device is provided, on the external surface, with a fluorescent marker and with a biological function whose receptors are overexpressed from the most type of human cancer cells; The drug is loaded in the pores, the release mechanism can be based on diffusion if adsorbed or on the pH differences between extracellular environment and endosomes if bonded. Bifunctional hybrid mesoporous silica potentially useful for drug targeting has been synthesized starting from neutral surfactant-templated mesoporous silica and covalently coupling folic acid preferentially on the external surface of the particles Folic acid is the tested receptor-specific ligand Folic acid, shows a great promise as a tumour-homing agent in the preparation of devices for drug targeting to cancer cells. This essential vitamin has a high affinity for FR (Folate Receptors), which can actively internalize bound folates and folate conjugated compounds via receptormediated endocytosis. Furthermore, FR are over-expressed by several kinds of cancer cells. Thus folate conjugation to anti-cancer drugs will improve drug selectivity and decrease negative side effects. Preparation of bifunctional mesoporous silica potentially useful for drug targeting L. PASQUA, F. TESTA, R. AIELLO, S. CUNDARI and J. B.NAGY, Microporous and Mesoporous Materials 103 (2007), 166-173. Luigi Pasqua, Flaviano Testa, Rosario Aiello, Umberto Maione, PCT/IT2006/000167 Functionalization of mesoporous silica with APTES OCH2CH3 CH3CH2O Si CH3CH2O CH2CH2CH2NH2 N N C N b a H N C N O H f C N O H R O c R-COOH R O Si O O + H2N d O Si O O HN O e The use of dicyclohexylcarbodiimides for folic acid coupling (DCC or DIPC)is an heritage of solid phase peptide synthesis Folic acid is retained on the surface of mesoporous silica also when the same coupling reaction is carried out without DCC or DIPC This is due to ammonium salt formation between amino group and carboxilic group of folic acid. The single reflection of XRD pattern of APMS1 and surfactant extracted FAPMS1 are shown. The uniform mesoporous structure of APMS1 is quite maintained after coupling reaction and extraction procedure although a partial broadening of silica as a consequence of the different chemical treatments can be noted Nitrogen adsorption–desorption isotherms of FAPMS1 before (bottom curve) and after surfactant extraction (top curve). As expected, the pore volume increases considerably after surfactant removal. The chemical characterization of the folatederivatized material cannot be unambiguously carried out because of the complexity of the hybrid material. FT-IR spectrum of FAPMS2 sample ( 793 cm-1 N–H out of plane wagging; 1417 cm-1 C–N amides stretching; 1531, 1608 cm-1 N–H bending; 1670–1700 cm-1 CO amides stretching; 3106 cm-1 C–H aromatic stretching) gives strong evidence of the association of folic acid on the functional silica matrix. To overcome this problems a series of parallel experiments has been carried out in order to reveal the chemical structure of the folatederivatized material. The coupling reaction was carried out on unfunctionalized mesoporous silica and on the aminopropyl mesoporous silica without the use of DCC so disabling, in the latter case, the reaction system to produce amide bond with alpha or gamma carboxylic groups of folic acid. Furthermore, in order to subtract the contribution of the surfactant during chemical characterization of the material, a pure silica matrix (BDH silica) functionalized with aminopropyl groups (BDH silica and APTES in refluxing toluene for 7 h) has been employed, as reference, in the coupling reaction with folic acid, (with and without DCC) . BDH silica functionalized with aminopropyl groups has been coupled with heptanoic acid, a simple molecule able to condense with amide bond formation Folic acid is associated to the silica matrix (mesoporous materials and BDH silica) both during the coupling reaction with and without DCC (blank proof); in the latter case the interaction is of electrostatic. Folic acid is retained on the material obtained from coupling reaction with DCC upon acid treatment (HCl 0.3 M in EtOH) while it is removed, by the same treatment, from the material obtained from blank proof. The acid solution is not able to hydrolyse the amide bond at room temperature while protonation is able to labilize the electrostatic interaction between folic acid and the 3aminopropylsilica. 3-aminopropylsilica (BDH) (curve I); 3-aminopropylsilica (BDH) coupled with folic acid without DCC after acid treatment (curve II) and with DCC after acid treatment (curve III). Drug release profiles of CP. As expected, the release is faster from MS compared to APMS1 and FAPMS1. This behaviour is probably due to both to steric hindrance and chemical interaction between CP and functionalised matrices. Preparation Steps Synthesis of PEG-templated mesoporous silica 1 SiO2-0.52 decane - 0.324 Triton X-100-126.2 H2O MSN 3-aminopropyltriethoxysilane functionalization MSN-AP Functionalization with folic acid MSN-FOL Cisplatin loading MSN-FOL-Cp N2 adsorptiondesorption isotherms and BJH adsorption pore size distribution (insets) of MSNs: a MSNExtracted and b MSN-Fol MSN SBET of 778 m2g-1 and PV at P/P0=0.9 of 0.50 cm3g-1. MSN-FOL SBET of 460 m2g-1, PV at P/P0=0.9 of 0.48 cm3g-1 TEM micrographs of MSN-FOL material exhibits a porous texture in adherence with materials of the MSU family . SEM images show that this synthesis procedure yields nanoscaled particles without a regular morphology appearing as aggregates of up to 500 nm. Dynamic light scattering (DLS) measurements of all functionalized particles showed that, when suspended in water, their average size distribution ranges between 100 to 300 nm Fluoresceina Cisplatino C. Morelli, P. Maris, D. Sisci, E. Perrotta, E. Brunelli, I. Perrotta, M. L. Panno, A. Tagarelli, C. Versace, M. F. Casula, F. Testa, S. Ando, J. B. Nagy ,L. Pasqua* Nanoscale, 2011, 3, 3198 Interestingly, MSN never entered HeLa , nor other cancerous (T47D, MCF-7 and SKBR3) and normal (HEK293) cell lines, indicating that calcined, non functionalized, particles are inert and do not interact with the biological systems. Successively, we questioned whether the cellular uptake depends on the electrostatic interactions between the protonated aminopropyl (AP) groups bound to the particles surface and the negatively charged cell membranes. The results showed that AP groups do not significantly affect the endocytotic process, In all cell lines, particle uptake occurs as soon as after 1 h of incubation and the majority of cells appear free of particles within 96 h, clearly underlining MSNs biocompatibility. Colloidal-gold labelling for FR unambiguously demonstrated that MSN-FOL enter HeLa cells through FR mediated endocytosis. As expected, a strong growth arrest was observed after one day in MSNFOLCp treated HeLa cells, if compared to the less dramatic growth retardation caused by comparable amounts of free Cp 1) Intravenous administration of highly fluorescent FITC-MS in healthy mices. 2) Intraperitoneal administration of highly fluorescent FITC-MS in healthy mices. Luigi PASQUA Antonella LEGGIO Catia MORELLI NanoSiliCal Devices is a recently founded spin-off company in the University of Calabria devoted to the production of mesoporous silica-based smart devices for targeting and release of biologically active molecules. PRODUCTS: -Patent licensing -MSN provided with a mechanism able to release a drug in intracellular compartment and a targeting function; -Mesoporous silica-based systems for controlled drug release; -Fluorescent MSN as imaging diagnostics; -MSN for gene therapy Bibliography Pasqua L, Testa F, Aiello R, Cundari S, Nagy JB. Micropor Mesopor Mat. 2007;103:166-73. Pasqua L, C. Morelli, F. Testa, D. Sisci, E. Brunelli, R. Aiello, S. and, J. B.Nagy (2007). Stud. Surf. Sci. Catal., vol. 170, ISSN: 0167-2991 Pasqua L, Cundari S., Ceresa C., Cavaletti G. (2009). Curr Med Chem vol. 16, p. 3054-3063, ISSN: 0929-8673 C. Morelli, P. Maris, D. Sisci, E. Perrotta, E. Brunelli, I. Perrotta, M.L. Panno, A. Tagarelli, C. Versace, M.F. Casula, F. Testa,S. Andò, J.B. Nagy and L. Pasqua. Nanoscale. 2011;3:3198-207. Ceresa C, Nicolini G, Rigolio R, Bossi M, Pasqua L, Cavaletti. G. Curr Med Chem. 2013;20:2589-600. AIELLO R, MAIONE U, PASQUA L, TESTA F (2006). PCT/IT2006/000167, UNIVERSITA' DELLA CALABRIA